Hemoglobin glutamer-250 (bovine, HbO2 Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHemoglobin glutamer-250 (bovine, HbO2 Therapeutics)
Drug Alias NameHemoglobin glutamer-250 (bovine)Bovine haemoglobin-HbO2 Therapeutics,Bovine hemoglobin-OPK Biotech, Hemoglobin glutamer-250-HbO2 TherapeuticsHemopureHBOC-201
ClassificationBiologics > Blood components
Mechanisms of ActionOxygen carriersHemoglobins stimulants
TargetsHemoglobins
Therapy Area/IndicationsWounds and InjuriesAnemiaPeripheral Vascular Diseases +[9] 
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Africa
Original Approved Date2010/01/01
Country/TerritoryBelgiumNetherlandsSouth Africa +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiopure CorporationHbo2 Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiopure Corporation
Active IndicationsAnemia
Inactive IndicationsWounds and InjuriesPeripheral Vascular DiseasesMyocardial Infarction +[8] 

Other Information

ATC CodeB05AA10
Related LinksKEGG